The SANAD study of effectiveness of valproate, lamotrigine, or topiramate for generalised and unclassifiable epilepsy: an unblinded randomised controlled trial
Top Cited Papers
- 1 March 2007
- journal article
- research article
- Published by Elsevier BV in The Lancet
- Vol. 369 (9566), 1016-1026
- https://doi.org/10.1016/s0140-6736(07)60461-9
Abstract
No abstract availableKeywords
Funding Information
- Health Technology Assessment Programme
This publication has 19 references indexed in Scilit:
- The SANAD study of effectiveness of carbamazepine, gabapentin, lamotrigine, oxcarbazepine, or topiramate for treatment of partial epilepsy: an unblinded randomised controlled trialThe Lancet, 2007
- Malformation risks of antiepileptic drugs in pregnancy: a prospective study from the UK Epilepsy and Pregnancy RegisterJournal of Neurology, Neurosurgery & Psychiatry, 2006
- Ethosuximide, sodium valproate or lamotrigine for absence seizures in children and adolescentsPublished by Wiley ,2005
- Topiramate, carbamazepine and valproate monotherapy: double-blind comparison in newly diagnosed epilepsyActa Neurologica Scandinavica, 2003
- Carbamazepine versus Valproate Monotherapy for Epilepsy: A Meta‐analysisEpilepsia, 2002
- Double‐Blind, Placebo‐Controlled, Lamotrigine in Treatment‐Resistant Generalised EpilepsyEpilepsia, 1998
- The Efficacy of Lamotrigine in Children and Adolescents with Refractory Generalized Epilepsy: A Randomized, Double‐Blind, Crossover StudyEpilepsia, 1998
- Proposal for Revised Classification of Epilepsies and Epileptic SyndromesEpilepsia, 1989
- Exacerbation of Seizures in Children by CarbamazepineNew England Journal of Medicine, 1985
- Proposal for Revised Clinical and Electroencephalographic Classification of Epileptic SeizuresEpilepsia, 1981